Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis.

ABSTRACT:

Background

Recently, several rare variants of SPTLC1 were identified as disease cause for juvenile amyotrophic lateral sclerosis (ALS) by disrupting the normal homeostatic regulation of serine palmitoyltransferase (SPT). However, further exploration of the rare variants in large cohorts was still necessary. Meanwhile, SPTLC2 plays a similar role as SPTLC1 in the SPT function.

Methods

To explore the genetic role of SPTLC1 and SPTLC2 in ALS, we analyzed the rare protein-coding variants in 2011 patients with ALS and 3298 controls from the Chinese population with whole exome sequencing. Fisher's exact test was performed between each variant and disease risk, while at gene level over-representation of rare variants in patients was examined with optimized sequence kernel associati

SUBMITTER: Li C 

PROVIDER: S-EPMC10040122 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature